{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:57Z","timestamp":1787009037209,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1093\/jac\/dkx010","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T02:01:30Z","timestamp":1486519290000},"page":"1969-1976","source":"Crossref","is-referenced-by-count":42,"title":["The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp."],"prefix":"10.1093","volume":"72","author":[{"given":"Laura Judith","family":"Marcos-Zambrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"G\u00f3mez-Perosanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Guinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"key\n\t\t\t\t20170616060942_dkx010-B1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B3","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/mmy\/myv094","article-title":"Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production","volume":"54","year":"2016","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B5","doi-asserted-by":"crossref","first-page":"S618","DOI":"10.1093\/cid\/civ815","article-title":"The role of echinocandins in Candida biofilm-related vascular catheter infections: in vitro and in vivo model systems","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B6","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.02541-12","article-title":"Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B7","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/AAC.00262-08","article-title":"A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B9","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs","volume":"6","year":"2011","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B11","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1517\/13543776.2011.603899","article-title":"New \u03b2-glucan inhibitors as antifungal drugs","volume":"21","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B12","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/AAC.02145-13","article-title":"Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant Candida species and Aspergillus species isolates","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/AAC.01588-12","article-title":"In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/jac\/dks466","article-title":"Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B15","first-page":"322","volume-title":"PCR Protocols: A Guide to Methods and Applications","year":"1990"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B16","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1128\/AAC.01032-13","article-title":"Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.02155-13","article-title":"Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B18","first-page":"e01542","year":"2017"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B19","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B20","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B21","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","year":"2008","journal-title":"Nat Protoc"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijmm.2014.08.012","article-title":"Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points","volume":"304","year":"2014","journal-title":"Int J Med Microbiol"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diagmicrobio.2006.09.003","article-title":"Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus","volume":"57","year":"2007","journal-title":"Diag Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diagmicrobio.2006.03.004","article-title":"Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus","volume":"56","year":"2006","journal-title":"Diag Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B25","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1128\/AAC.00123-14","article-title":"Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B26","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.06369-11","article-title":"Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B28","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B29","doi-asserted-by":"crossref","first-page":"O245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain","volume":"20","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170616060942_dkx010-B31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.04445-14","article-title":"Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/7\/1969\/17723349\/dkx010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:09:15Z","timestamp":1692662955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkx010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,4,26]]},"published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx010","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]}}}